Isoniazid
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.50 | $45.00 (0%) | 🛒 Add to cart |
| 120 | $0.46 | $60.00 $55.00 (8%) | 🛒 Add to cart |
| 180 | $0.42 | $90.00 $75.00 (17%) | 🛒 Add to cart |
| 270 | $0.39 | $135.00 $106.00 (21%) | 🛒 Add to cart |
| 360 | $0.38
Best per pill | $180.00 $136.00 (24%) | 🛒 Add to cart |
Synonyms
| |||
More info:
Dilantin: Seizure Control with Established Efficacy
Dilantin (phenytoin) is a cornerstone anticonvulsant medication with a long-standing history in neurological therapeutics. As a hydantoin derivative, it is primarily indicated for the management and prevention of tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures. Its mechanism of action involves the stabilization of neuronal membranes and the reduction of the maximal activity of brain stem centers responsible for the tonic phase of grand mal seizures, primarily through use-dependent blockade of voltage-gated sodium channels.
Mysoline: Effective Seizure Control with Established Reliability
Mysoline (primidone) is an established anticonvulsant medication indicated for the management of seizure disorders. As a barbiturate derivative, it exerts its therapeutic effect by decreasing abnormal electrical activity in the brain, thereby reducing the incidence and severity of epileptic episodes. This product card provides a comprehensive, expert-level overview of its pharmacological profile, clinical application, and essential safety information for healthcare professionals and informed patients. Its long history of use has solidified its role in specific treatment protocols, particularly for certain types of seizures where other medications may be insufficient or not tolerated.
Tegretol: Effective Seizure Control and Neuropathic Pain Relief
Tegretol (carbamazepine) is a well-established anticonvulsant and mood-stabilizing medication primarily indicated for the management of epilepsy and trigeminal neuralgia. With decades of clinical use and extensive research supporting its efficacy, it remains a cornerstone therapy for controlling partial and generalized tonic-clonic seizures. Its mechanism of action involves use-dependent blockade of voltage-gated sodium channels, stabilizing hyperexcited neuronal membranes and inhibiting repetitive firing. Available in various formulations including tablets, chewable tablets, and suspension, it offers flexibility in dosing tailored to individual patient needs and therapeutic response.
Advanced Diclofenac Emulgel for Targeted Pain Relief
Diclofenac Emulgel represents a significant advancement in topical analgesic therapy, combining the proven efficacy of diclofenac with innovative emulsion gel technology. This pharmaceutical formulation is specifically engineered to provide targeted relief from musculoskeletal pain and inflammation while minimizing systemic exposure. Developed through extensive clinical research, this emulgel offers healthcare professionals and patients a sophisticated alternative to oral NSAIDs, particularly for localized conditions where direct application is advantageous. Its unique carrier system ensures optimal drug penetration and bioavailability at the site of application.
Arava: Targeted Symptom Control for Rheumatoid Arthritis
Arava (leflunomide) is a disease-modifying antirheumatic drug (DMARD) specifically engineered to manage the symptoms and progression of rheumatoid arthritis. By selectively inhibiting pyrimidine synthesis in activated lymphocytes, it reduces inflammation, minimizes joint damage, and helps preserve physical function. This oral treatment offers a convenient therapeutic option for adults with moderate to severe active rheumatoid arthritis, providing sustained relief and improving quality of life. Clinical studies demonstrate its efficacy in reducing tender and swollen joint counts and slowing radiographic progression.
Arcoxia: Targeted Relief for Chronic Osteoarthritis and Pain
Arcoxia (etoricoxib) is a prescription medication belonging to the class of drugs known as selective COX-2 inhibitors, a type of nonsteroidal anti-inflammatory drug (NSAID). It is specifically engineered to provide potent anti-inflammatory and analgesic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for pain and inflammation, while largely sparing the COX-1 enzyme involved in protecting the stomach lining. This mechanism offers a refined approach to managing chronic musculoskeletal conditions, particularly osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as acute gouty arthritis and primary dysmenorrhea.
Aristocort: Advanced Topical Corticosteroid for Effective Inflammation Control
Aristocort (triamcinolone acetonide) is a mid-potency corticosteroid formulation designed for targeted anti-inflammatory and immunosuppressive action. As a trusted dermatological and systemic therapeutic agent, it offers physicians a versatile tool for managing a spectrum of inflammatory, allergic, and autoimmune conditions. Its well-established efficacy profile and multiple delivery forms—including creams, ointments, lotions, and injectable suspensions—make it a cornerstone in clinical practice for both acute flare management and chronic condition control. Features Contains triamcinolone acetonide, a synthetic glucocorticoid Available in multiple formulations: cream (0.
Asacol: Targeted Relief for Ulcerative Colitis Symptoms
Asacol (mesalamine) is a prescription medication specifically formulated for the treatment of mild to moderate ulcerative colitis. It belongs to the class of aminosalicylates and works locally in the colon to reduce inflammation, helping to induce and maintain remission. This delayed-release formulation ensures the active ingredient is delivered directly to the site of disease activity, minimizing systemic absorption and optimizing therapeutic efficacy for appropriate patients under medical supervision. Features Active ingredient: Mesalamine (5-aminosalicylic acid or 5-ASA) Formulation: Delayed-release tablets designed for targeted colonic release Available strengths: 400 mg and 800 mg delayed-release tablets pH-dependent coating that dissolves at pH ≥7, typically in the terminal ileum and colon Designed to minimize systemic absorption while maximizing local anti-inflammatory effects Benefits Effectively reduces inflammation in the colon to control ulcerative colitis symptoms Helps achieve and maintain clinical remission in mild to moderate cases Targeted delivery system minimizes systemic exposure and potential side effects Demonstrated efficacy in reducing relapse rates when used as maintenance therapy Generally well-tolerated with a favorable safety profile compared to systemic therapies Convenient oral administration that supports long-term treatment adherence Common use Asacol is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older.
Benemid: The Proven Uricosuric Agent for Effective Gout Management
Benemid (probenecid) is a long-established uricosuric medication specifically designed for the chronic management of hyperuricemia associated with gout and gouty arthritis. By effectively increasing the renal excretion of uric acid, it directly targets the underlying metabolic imbalance responsible for painful crystal deposition. This therapeutic action helps to reduce serum urate levels, prevent the formation of new tophi, and decrease the frequency of debilitating acute gout attacks, offering patients a path toward long-term disease control and improved quality of life.